Web-based Daily Care Training of Children With Cerebral Palsy

NCT02545179 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-09-10

No results posted yet for this study

Summary

Purpose:Effect of web-based daily care training on the quality of life of caregivers of children with cerebral palsy.

study design: Single-blind clinical trial. study population: Caregivers of children with cerebral palsy. Inclusion criteria: caregiver -Mother of a child with cerebral palsy who spent most time on child care- Children with cerebral palsy aged 4 to 12 years old living in Alborz province that clinical diagnosis of cerebral palsy registered in their clinical records. Moderate and severe cerebral palsy (gross motor function levels 3 to 5). caregiver have facilities and basic knowledge of using Internet (Declared access to the Internet at least one hour a week). exclusion criteria: taking care of two or more children with disability. participated in previous face to face training programs.

Sample size: 100. Intervention: Web-based daily care training. intervention time: 12-week. Outcome of the study: the quality of life of caregivers

Conditions

  • Cerebral Palsy

Interventions

OTHER

web-based daily care training

12 week interactive web based caring training education

Sponsors & Collaborators

  • University of Social Welfare and Rehabilitation Science

    lead OTHER

Principal Investigators

  • Zahra Nobakht, PhD student · Occupational therapy department, University of Social Welfare and Rehabilitation Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2016-01-31
Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02545179 on ClinicalTrials.gov